BOULDER, Colo.–(BUSINESS WIRE)–Enveda Biosciences (“Enveda”), a biotechnology company using AI to translate nature into new medicines, announced today the appointment of José Trevejo M.D. Ph.D., as Chief Medical Officer and Head of Clinical Pipeline Strategy. In this role, Dr. Trevejo will lead the clinical organization and oversee the advancement of Enveda’s robust pipeline that spans multiple therapeutic areas. Dr. Trevejo joins Enveda following a string of recent successes, most recently a
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
